Antibody-Recruiting Molecules targeting HIV (Kleo Pharmaceuticals)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameAntibody-Recruiting Molecules targeting HIV (Kleo Pharmaceuticals)
Drug Alias NameAntibody-Recruiting Molecules targeting HIV (Yale University)ARM-H-3ARM-H-1ARM-H
ClassificationSmall molecules
Mechanisms of ActionT-cell surface antigen CD4 inhibitorsHIV uptake inhibitorsHIV envelope protein gp120 modulators
TargetsHIV envelope protein gp120T-cell surface antigen CD4
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesYale University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesYale UniversityKleo Pharmaceuticals
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A